| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.17B | 142.78B | 126.90B | 113.47B | 94.18B | 81.08B |
| Gross Profit | 73.33B | 78.55B | 69.29B | 57.39B | 42.13B | 34.03B |
| EBITDA | 23.88B | 21.80B | 17.74B | 14.59B | -5.41B | -71.65B |
| Net Income | 16.14B | 18.62B | 15.34B | 6.40B | -13.69B | -78.08B |
Balance Sheet | ||||||
| Total Assets | 155.54B | 164.57B | 139.87B | 106.30B | 89.31B | 92.52B |
| Cash, Cash Equivalents and Short-Term Investments | 57.15B | 62.42B | 51.50B | 48.86B | 35.41B | 45.28B |
| Total Debt | 36.53B | 23.01B | 29.53B | 15.72B | 12.93B | 13.61B |
| Total Liabilities | 84.82B | 84.96B | 77.85B | 57.22B | 49.47B | 47.42B |
| Stockholders Equity | 70.70B | 79.59B | 62.00B | 49.06B | 39.83B | 45.09B |
Cash Flow | ||||||
| Free Cash Flow | 10.70B | 12.45B | 21.72B | 15.88B | -2.42B | -13.28B |
| Operating Cash Flow | 16.38B | 27.00B | 29.79B | 20.78B | 2.20B | -5.52B |
| Investing Cash Flow | -17.95B | -26.36B | -36.68B | -19.86B | -17.55B | -18.36B |
| Financing Cash Flow | 2.87B | -1.88B | 6.71B | -1.36B | -4.48B | 36.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$103.28B | 12.16 | 10.97% | 1.01% | 17.42% | -3.31% | |
71 Outperform | HK$4.11T | 16.70 | 19.90% | 0.75% | 14.96% | 21.57% | |
68 Neutral | HK$208.08B | 13.58 | 25.63% | ― | 12.62% | 22.16% | |
65 Neutral | HK$15.80B | -128.76 | 12.13% | 8.13% | 0.06% | 48.33% | |
61 Neutral | HK$1.92B | 7.67 | 6.72% | 4.08% | -25.20% | 33.72% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
51 Neutral | HK$2.03B | -3.19 | -4.72% | ― | -23.64% | -42.22% |